A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

NCT04622293 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Chronic Fatigue Syndrome
Myalgic Encephalomyelitis

Interventions

DRUG: Solriamfetol Oral Tablet [Sunosi]
DRUG: Placebo

Sponsor

Rochester Center for Behavioral Medicine